275 related articles for article (PubMed ID: 11505214)
1. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
Park-Holohan SJ; Blake GM; Fogelman I
Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
[TBL] [Abstract][Full Text] [Related]
2. Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.
Blake GM; Park-Holohan SJ; Fogelman I
J Nucl Med; 2002 Mar; 43(3):338-45. PubMed ID: 11884493
[TBL] [Abstract][Full Text] [Related]
3. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
[TBL] [Abstract][Full Text] [Related]
4. Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2008 Mar; 49(3):375-82. PubMed ID: 18287266
[TBL] [Abstract][Full Text] [Related]
5. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
Moore AE; Hain SF; Blake GM; Fogelman I
J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
[TBL] [Abstract][Full Text] [Related]
6. Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.
Moore AE; Blake GM; Fogelman I
J Nucl Med; 2006 Apr; 47(4):581-6. PubMed ID: 16595490
[TBL] [Abstract][Full Text] [Related]
7. Studies on diphosphonate kinetics. Part I: Evaluation of plasma elimination curves during 24 h.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):581-4. PubMed ID: 3107990
[TBL] [Abstract][Full Text] [Related]
8. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
Moore AE; Blake GM; Fogelman I
Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?
Blake GM; Siddique M; Frost ML; Moore AE; Fogelman I
Bone; 2011 Sep; 49(3):537-42. PubMed ID: 21689803
[TBL] [Abstract][Full Text] [Related]
10. Studies on diphosphonate kinetics. Part II: Whole body bone uptake rate during constant infusion--a refined index of bone metabolism.
Hyldstrup L; McNair P; Ring P; Henriksen O
Eur J Nucl Med; 1987; 12(12):585-8. PubMed ID: 3107991
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
Chakraborty D; Bhattacharya A; Mete UK; Mittal BR
Clin Nucl Med; 2013 Aug; 38(8):616-21. PubMed ID: 23603596
[TBL] [Abstract][Full Text] [Related]
12. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
13. Chromium 51 EDTA/technetium 99m MDP plasma ratio to measure total skeletal function.
Nisbet AP; Edwards S; Lazarus CR; Malamitsi J; Maisey MN; Mashiter GD; Winn PJ
Br J Radiol; 1984 Aug; 57(680):677-80. PubMed ID: 6235885
[TBL] [Abstract][Full Text] [Related]
14. Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent.
Moore AE; Park-Holohan SJ; Blake GM; Fogelman I
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):4-8. PubMed ID: 12483403
[TBL] [Abstract][Full Text] [Related]
15. Comparison of simultaneous plasma clearance of
Andersen TB; Jødal L; Nielsen NS; Petersen LJ
Scand J Clin Lab Invest; 2019 Nov; 79(7):463-467. PubMed ID: 31502901
[TBL] [Abstract][Full Text] [Related]
16. Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.
Moore AE; Blake GM; Taylor KA; Rana AE; Wong M; Chen P; Fogelman I
J Bone Miner Res; 2010 May; 25(5):960-7. PubMed ID: 19929434
[TBL] [Abstract][Full Text] [Related]
17. Renal and extrarenal clearance of 99mTc-MAG3: a comparison with 125I-OIH and 51Cr-EDTA in patients representing all levels of glomerular filtration rate.
Rehling M; Nielsen BV; Pedersen EB; Nielsen LE; Hansen HE; Bacher T
Eur J Nucl Med; 1995 Dec; 22(12):1379-84. PubMed ID: 8586082
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis.
Moore AE; Blake GM; Taylor KA; Ruff VA; Rana AE; Wan X; Fogelman I
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):326-36. PubMed ID: 22057627
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.
Yen RF; Chen CY; Cheng MF; Wu YW; Shiau YC; Wu K; Hong RL; Yu CJ; Wang KL; Yang RS
Nucl Med Commun; 2010 Jul; 31(7):637-45. PubMed ID: 20389259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]